American Association for the Study of Liver Diseases
The American Association for the Study of Liver Diseases (AASLD) is the nation’s premier organization of physicians, scientists, researchers, medical students, and healthcare professionals to study, prevent, and cure liver diseases. AASLD was founded in 1950 by a group of leading liver specialists to advance the field of hepatology. The mission of AASLD is to advance and disseminate the science and practice of hepatology and to promote improved liver health and quality patient care. AASLD has more than 7,000 + members who work in hepatology and related areas. AASLD advances the study and treatment of liver diseases in these diverse ways: · The Liver Meeting, AASLD’s annual meeting that features interactive sessions on the latest breakthroughs, advancements, and research in liver health, education workshops, and exhibits featuring state-of-the-art technologies, pharmaceutical developments, and medical devices. · Practice guidelines developed by a multidisciplinary panel of experts to share recommended approaches to the diagnosis, therapeutic, and preventive aspects of care along with quality measures to help its members measure healthcare processes and outcomes. · Journals that feature the latest research, review, practice guidelines and more on liver disease. These include Hepatology, the premier publication in the field of liver disease; Clinical Liver Disease, a free access multimedia review journal; and Hepatology Communications, a peer-reviewed, online, and open access journal. · Clinical resources for hepatologists and other clinicians. · Courses for clinicians and other healthcare professionals. · Tools to help professionals communicate effectively with patients. · The Cirrhosis Quality Collaborative, a multi-site learning health network that combines quality improvement and research to improve the care and treatment of patients with cirrhosis.www.aasld.org
4
MENTIONS
4
EPISODES
4
PODCASTS
Search complete. 4 mentions across 4 episodes found for "American Association for the Study of Liver Diseases".
Sep 24, 2026
Mazen NoureddinGUEST
We did not recommend checking thyroid panel, TSH, or free T4.
Mazen NoureddinGUEST
The American Society of Liver Disease added that after testing.
Mazen NoureddinGUEST
adding endocrinologists on their panel, it's okay to be careful.
Mazen NoureddinGUEST
That's totally fine.
Alison KearneyGUEST
I have, if you want, if the, if the listeners are keen on something that's very, um, short and, uh, prescriptive, the Scottish palliative care guidelines are, are very good, um, uh, for end-stage liver disease and they're easy to find on, uh, Google search.
Alison KearneyGUEST
There's also a couple of statement position papers published by the AASLD in 2022 in hepatology and also the easel position paper, which is actually only published this year.
Alison KearneyGUEST
So that's an up-to-date resource to have a look at.
Alison KearneyGUEST
They're a bit more detailed regarding symptom management advice.
Richard S. FinnGUEST
Patients with diabetes, we need to keep in mind that they are at risk for developing liver disease.
Richard S. FinnGUEST
And, you know, for patients who we know have cirrhosis, Many of us recommend, and when I say many of us, not only doctors interested in liver cancer, but subspecialty societies such as the American Association of Liver Disease and other national prominent organizations recommend screening for liver cancer.
Richard S. FinnGUEST
What does that mean? Well, the idea is define liver cancer early when we can cure it and control it much better than when it's advanced.
Richard S. FinnGUEST
And there isn't a lot of awareness, I would argue, in the primary care community of the importance of screening for liver cancer in patients who are at risk.
Clete BarrickHOST
The fix isn't monthly blood draws.
Clete BarrickHOST
In November 2025, the American Association for the Study of Liver Diseases announced updated its guidance.
Clete BarrickHOST
No routine liver panels.
Clete BarrickHOST
Check when there's a reason.